Analysts at Jefferies estimate that a 10% reduction in average passenger weight—driven by wider adoption of next-generation oral GLP-1 weight-loss drugs—would lower total aircraft weight by roughly 2%, delivering up to 1.5% in fuel‐cost savings and translating into an estimated 4% uplift to earnings per share across major U.S. carriers. Given American Airlines’ higher operating leverage to fuel costs, Jefferies projects potential EPS gains of approximately 11.7% for the airline. With the four largest U.S. carriers expected to consume some 16 billion gallons of jet fuel in 2026—representing nearly 19% of their combined operating expenses—any weight-related efficiency gains could meaningfully augment American’s profitability over thousands of flights each year.

On January 13, American Airlines’ shares declined by 4.06%, underperforming broader market benchmarks and falling more steeply than several peers. Trading volume reached about 82 million shares, roughly 47% above the three-month average, as investors reacted to a mixed earnings outlook from Delta Air Lines and renewed concerns over a potential cap on credit-card interest rates. Delta’s commentary on its co-branded card economics—and its assertion that more affluent customers would better absorb any rate limits—sparked fears that American’s loyalty-program margins could face pressure, exacerbating the stock’s sell-off.

American Airlines Group has scheduled a live webcast of its fourth-quarter and full-year 2025 financial results conference call for January 27 at 7:30 a.m. Central Time. The listen-only audio feed will be accessible via the company’s investor relations website, with an archive available following the call. Investors and analysts will be looking for management’s commentary on fuel-cost trends, capacity guidance for 2026, and profitability initiatives in light of evolving market dynamics.